KR101891951B1 - Mask pack comprising emulsion composition containing peach-extract - Google Patents

Mask pack comprising emulsion composition containing peach-extract Download PDF

Info

Publication number
KR101891951B1
KR101891951B1 KR1020170184874A KR20170184874A KR101891951B1 KR 101891951 B1 KR101891951 B1 KR 101891951B1 KR 1020170184874 A KR1020170184874 A KR 1020170184874A KR 20170184874 A KR20170184874 A KR 20170184874A KR 101891951 B1 KR101891951 B1 KR 101891951B1
Authority
KR
South Korea
Prior art keywords
weight
extract
composition
skin
sodium
Prior art date
Application number
KR1020170184874A
Other languages
Korean (ko)
Inventor
유서연
Original Assignee
유서연
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 유서연 filed Critical 유서연
Priority to KR1020170184874A priority Critical patent/KR101891951B1/en
Application granted granted Critical
Publication of KR101891951B1 publication Critical patent/KR101891951B1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0212Face masks
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04Dispersions; Emulsions
    • A61K8/06Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/345Alcohols containing more than one hydroxy group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/28Rubbing or scrubbing compositions; Peeling or abrasive compositions; Containing exfoliants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Cosmetics (AREA)

Abstract

The present invention provides a mask pack including an emulsion composition. The emulsion composition includes: 1-8 wt% of glycerin; 1-5 wt% of sodium hyaluronate; 1-7 wt% of a peach extract; 0.5-4 wt% of a licorice extract; 1-8 wt% of sodium acetylated hyaluronate; 0.1-2 wt% of hydrolyzed hyaluronic acid; 0.1-3 wt% of hydrolyzed collagen; 0.1-3 wt% of a lemon extract; 0.1-3 wt% of sugar; 0.1-3 wt% of a maple extract; 0.1-3 wt% of extracts of bilberries and leaves thereof; 0.1-3 wt% of a sugar cane extract; 0.1-3 wt% of an orange extract; 0.1-3 wt% of a Portulaca oleracea extract; 0.1-3 wt% of a tea tree extract; 0.1-3 wt% of a bergamot leaf extract; 0.1-3 wt% of bamboo water; 0.1-3 wt% of a camellia flower extract; 0.1-3 wt% of panthenol dipotassium glycyrrhizate; 0.1-3 wt% of allantoin; 0.1-3 wt% of a betaine glyceryl acrylate/acrylic acid copolymer; 0.1-3 wt% of a PVM/MA copolymer; 1-7 wt% of propylene glycol; 0.1-3 wt% of a hydroxy ethyl acrylate/sodium acryloyl dimethyl taurate copolymer; 0.01-0.3 wt% of xanthan gum; 0.05-2 wt% of PEG-60 Hydrogenated castor oil; 0.1-1 wt% of 1,2-hexane diol; 0.1-1 wt% of hydroxyacetophenone; 0.005-0.1 wt% of Disodium EDTA; 0.01-0.2 wt% of spice; and the remaining of purified water.

Description

복숭아 추출물을 함유한 에멀젼 조성물을 포함하는 마스크팩{MASK PACK COMPRISING EMULSION COMPOSITION CONTAINING PEACH-EXTRACT}MASK PACK COMPRISING EMULSION COMPOSITION CONTAINING PEACH-EXTRACT [0002] The present invention relates to a mask pack comprising an emulsion composition containing a peach extract,

본 발명은 복숭아 추출물을 함유한 에멀젼 조성물을 포함하는 마스크팩에 관한 것이다. The present invention relates to a mask pack comprising an emulsion composition containing peach extract.

현대사회는 배기가스, 유해 화학물질, 오존층의 파괴 등으로 자외선, 수질오염 등에 의한 활성산소가 대량으로 발생하고 있고, 이러한 활성산소는 인체에 침투하여 여러 가지 부작용을 일으키며, 특히 색소변화, 피부노화 등의 주요원인으로 알려지고 있다.In modern society, large amounts of active oxygen are generated by ultraviolet rays and water pollution due to exhaust gas, toxic chemical substances, destruction of ozone layer, etc. Such active oxygen penetrates into human body and causes various side effects. In particular, And the like.

또한, 근래에는 과중한 사회적, 업무적 스트레스를 해소하기 위하여 골프 등과 같은 야외에서의 레저활동이 증가하고 있는데, 이러한 야회에서의 레저활동 중에는 신체 피부가 상기한 오염원 등에 더욱 쉽게 직접적으로 노출되기 때문에 피부훼손 및 피부노화를 피할 수 없는 실정이어서 야외 레저활동을 보다 적극적이고 쾌적하게 즐기고자 하는 추세에 부정적인 영향을 미치고 있다.In addition, in recent years, outdoor leisure activities such as golf have been increasing in order to overcome the excessive social and work stress. During the leisure activities in such occasions, the body skin is more easily exposed directly to the above pollution sources, And skin aging can not be avoided. This has a negative effect on the tendency to enjoy outdoor leisure activities more positively and comfortably.

일반적으로 피부는 기본적인 신진대사 과정을 통하여 우리 몸의 항상성을 저해하는 다양한 외부 요인으로부터 위해를 막아주는 일차적인 기능을 담당하고 있다. 즉, 피부는 신체 가장 바깥쪽에 위치함으로써 물리적, 화학적, 생물학적 장벽기능을 통한 보호작용, 체온조절작용, 감각작용, 분비 및 배설작용, 흡수작용, 저장작용, 재생작용 등의 다양한 역할을 수행하고 있지만, 지속적인 외부 스트레스가 가해지는 경우 가장 손상을 받기 쉽다. 이러한 외부 스트레스의 주요 원인으로는 자외선 노출, 배기가스, 황사, 환경오염물, 중금속, 온도변화, 미생물을 대표적인 예로 들 수 있으며, 이들은 주로 산화적 스트레스(oxidative stress)를 통하여 활성산소종(reactive oxygen species, ROS)을 생성함으로써, 항산화 방어체계를 붕괴시켜 세포 손상 및 사멸을 야기하게 된다.In general, skin plays a primary role in preventing harm from various external factors that interfere with our homeostasis through basic metabolic processes. In other words, while the skin is located at the outermost position of the body, it plays various roles such as protection through physical, chemical and biological barrier functions, body temperature regulating action, sensory action, secretion and excretion action, absorption action, storage action and regeneration action , And most likely to be damaged if sustained external stress is applied. The main causes of external stresses are ultraviolet exposure, exhaust gas, dust, environmental pollutants, heavy metals, temperature changes and microorganisms. These are mainly caused by oxidative stress, reactive oxygen species , ROS), thereby destroying the antioxidant defense system and causing cell damage and death.

한편, 사람의 피부는 적정한 양의 수분을 보유하고 있어야 외견상 부드럽고 유연하고 건강하게 보인다. 이를 위해서는 건조한 환경에서도 수분 증발량이 낮게 유지되어야 한다. 피부가 건조하게 되면, 표피의 상층부가 거칠고 건조하며 유연성이 저하된다. 피부의 건조 상태가 심화되면 각질이 과도하게 탈리되거나 갈라지기도 하며, 심각한 경우에는 아예 피부질환으로 분류된다. 또한, 건조한 피부에서는 각질 세포 사이의 결합력이 약화되고, 지질 성분의 변화가 발생하며, 각질의 수분 보유력이 감소된다고 보고되어 있다.On the other hand, a person's skin must have an adequate amount of moisture to appear superficially soft, supple and healthy. This requires that the moisture evaporation be kept low even in a dry environment. When the skin becomes dry, the upper part of the epidermis becomes coarse, dry, and soft. If the dryness of the skin becomes deeper, the keratin is excessively torn or cracked, and in severe cases it is classified as skin disease at all. In dry skin, it has been reported that the binding force between keratinocytes is weakened, the lipid component is changed, and the retention of water content of keratin is decreased.

또한, 적정한 정도의 피부 수분 함량이 정상적인 피부 상태를 유지하는데 필수적인 요소이므로, 피부의 수분 함량을 유지하기 위한 피부 보습제의 연구가 지속적으로 수행되고 있다. 종래에 개발된 피부 보습제들은 단순히 피부를 보습하여 수분 함유량을 일시적으로 유지하게 할 수 있다. 그러나 이러한 보습제가 표피를 통과하여 피부 깊숙하게 침투하는 기능이나, 건조하기 쉽고 수분에 대한 장벽 기능을 하는 각질층에서 수분을 고정하는 기능이 매우 부족하여, 적정한 정도의 피부 수분 함량을 지속적으로 유지하는 것이 곤란하다는 문제점을 지니고 있다.In addition, since a proper amount of skin moisture is an essential factor for maintaining a normal skin condition, research on skin moisturizing agents for maintaining the moisture content of the skin is continuously carried out. Conventionally developed skin moisturizers can simply moisturize the skin and temporarily maintain the moisture content. However, these moisturizers penetrate deeply into the skin through the epidermis, and there is a very low ability to fix moisture in the stratum corneum which is easy to dry and has a barrier to moisture, so that the skin moisture content is maintained to an appropriate level It has the problem that it is difficult.

한편, 최근에 피부 미용을 목적으로 하는 피부관리, 특히 안면 피부관리를 위하여 미용 성분이 함유된 젤타입 또는 크림타입 마스크팩, 분말형태의 물질을 물과 혼합하여 사용하는 마스크팩이 주로 사용되고 있다. 이러한 마스크팩의 사용 방법으로는 안면을 클렌징하는 단계, 기능성 성분을 도포하는 단계, 기능성 성분(cosmetic ingredient)을 포함하는 마스크팩을 도포하거나 또는 부착하는 단계 및 마스크팩 또는 시트마스크를 제거하는 단계로 이루어질 수 있다.On the other hand, a gel type or cream type mask pack containing a cosmetic ingredient and a mask pack using a powder type substance mixed with water are mainly used for skin care, especially facial skin care, for skin care purpose. Methods of using such a mask pack include steps of cleansing the face, applying the functional ingredient, applying or attaching a mask pack comprising a functional ingredient (cosmetic ingredient), and removing the mask pack or sheet mask Lt; / RTI >

이와 같이, 마스크팩 산업은 빠른 속도로 발전하고 있다. 그러나 외형적인 발전속도와 비교하여 품질의 발전속도는 아직 미흡한 실정이다. 따라서 마스크팩의 사용횟수를 감소시키면서도, 보습, 미백, 항산화, 주름감소 등의 효과를 제공할 수 있는 효과적인 마스크팩의 제조가 요망되고 있다. As such, the mask pack industry is rapidly developing. However, the development speed of quality is still insufficient compared with the external development speed. Therefore, it is desired to produce an effective mask pack capable of providing effects such as moisturizing, whitening, antioxidation, and wrinkle reduction while reducing the number of times of use of the mask pack.

대한민국 공개특허 제10-2017-0056148호Korean Patent Publication No. 10-2017-0056148

본 발명은, 종래기술의 상기와 같은 단점을 해결하기 위하여 안출된 것으로서, 일주일에 단 1회의 사용만으로도 우수한 피부보습, 항산화, 미백, 및 주름개선의 효과를 제공할 수 있는 마스크팩을 제공하는 것을 목적으로 한다. Disclosure of the Invention The present invention has been conceived to solve the above-mentioned disadvantages of the prior art, and it is an object of the present invention to provide a mask pack which can provide excellent skin moisturizing, antioxidant, whitening, and wrinkle improvement effects only once a week The purpose.

본 발명은, According to the present invention,

글리세린 1~8 중량%, 소듐하이알루로네이트 1~5 중량%, 복숭아추출물 1~7 중량%, 감초추출물 0.5~4 중량%, 소듐아세틸레이티드하이알루로네이트 1~8 중량%, 하이드롤라이즈드하이알루로닉애씨드 0.1~2 중량%, 하이드롤라이즈드콜라겐 0.1~3 중량%, 레몬추출물 0.1~3 중량%, 설탕 0.1~3 중량%, 단풍추출물 0.1~3 중량%, 빌베리열매 및 잎추출물 0.1~3 중량%, 사탕수수추출물 0.1~3 중량%, 오렌지추출물 0.1~3 중량%, 마치현추출물 0.1~3 중량%, 티트리잎추출물 0.1~3 중량%, 베르가못잎추출물 0.1~3 중량%, 대나무수 0.1~3 중량%, 동백꽃추출물 0.1~3 중량%, 판테놀디포타슘글리시리제이트 0.1~3 중량%, 알란토인 0.1~3 중량%, 베타인글리세릴아크릴레이트/아크릴릭애씨드 코폴리머 0.1~3 중량%, 피브이엠/엠에이 코폴리머 0.1~3 중량%, 프로필렌글라이콜 1~7 중량%, 하이드록시에칠아크릴레이트/소듐아크릴로일디메칠타우레이트 코폴리머 0.1~3 중량%, 잔탄검 0.01~0.3 중량%, 피이지-60 하이드로제네이티드캐스터오일 0.05~2 중량%, 1,2-핵산디올 0.1~1 중량%, 하이드록시아세토페논 0.1~1 중량%, 디소듐이디티에이 0.005~0.1 중량%, 향료 0.01~0.2 중량%, 및 정제수 잔량을 포함하는 에멀젼 조성물을 포함하는 마스크팩에 관한 것이다.1 to 8 wt% of glycerin, 1 to 5 wt% of sodium hyaluronate, 1 to 7 wt% of peach extract, 0.5 to 4 wt% of licorice extract, 1 to 8 wt% of sodium acetylated hyaluronate, 0.1 to 3 wt% of lemon extract, 0.1 to 3 wt% of sugar, 0.1 to 3 wt% of leaf extract, 0.1 to 3 wt% of berry fruit, 0.1 to 3 wt% of leaf extract, 0.1 to 3 wt% of sugar cane extract, 0.1 to 3 wt% of orange extract, 0.1 to 3 wt% of horseradish extract, 0.1 to 3 wt% of tea tree leaf extract, 0.1 to 3 wt of bergamot leaf extract 0.1 to 3 wt% of bamboo water, 0.1 to 3 wt% of camellia extract, 0.1 to 3 wt% of panthenol dipotassium glycyrrhizate, 0.1 to 3 wt% of allantoin, 0.1 to 3 wt% of betaine glyceryl acrylate / acrylic acid copolymer, 3 wt.%, PVEM / MEA copolymer 0.1-3 wt.%, Propylene glycol 1-7 wt.%, Hydroxyethyl methacrylate / 0.1 to 3% by weight of acryloyldimethyltaurate copolymer, 0.01 to 0.3% by weight of xanthan gum, 0.05 to 2% by weight of hydrogenated castor oil, 0.1 to 1% by weight of 1,2-nucleic acid diol, The present invention relates to a mask pack comprising an emulsion composition comprising 0.1 to 1% by weight of a hydroxyacetophenone, 0.005 to 0.1% by weight of disodium iodide, 0.01 to 0.2% by weight of a perfume, and a purified water balance.

상기 에멀젼 조성물은 왕겨, 율피, 메밀껍질, 및 껍질 채로 건조한 작두콩을 1~3 : 1~3 : 1~3 : 1~3의 중량비로 혼합한 혼합물을 열수추출한 추출물 0.1~5 중량%를 더 포함하는 것을 특징을 가질 수 있다. The emulsion composition further comprises 0.1 to 5% by weight of an extract obtained by hot-water extracting a mixture of rice hull, hull, buckwheat husk, and husked dried soybeans at a weight ratio of 1: 3: 1 to 3: 1 to 3: And the like.

상기 에멀젼 조성물은 유화보조제로서 하기 화학식 1로 표시되는 화합물 0.1~3 중량%를 더 포함하는 특징을 가질 수 있다:The emulsion composition may further comprise 0.1 to 3% by weight of a compound represented by the following formula (1) as an emulsifying aid:

[화학식 1][Chemical Formula 1]

Figure 112017131383810-pat00001
Figure 112017131383810-pat00001

상기 식에서,In this formula,

n은 2~10의 자연수이고,n is a natural number of 2 to 10,

a 및 b는 몰분율으로서 a는 0.5 및 b는 0.5이며;a and b are molar fractions, a is 0.5 and b is 0.5;

c 및 d는 몰분율으로서, c는 0.05~0.2이며, d는 0.8~0.95이며, c+d는 1이다.c and d are mole fractions, c is 0.05 to 0.2, d is 0.8 to 0.95, and c + d is 1.

상기 마스크팩은 각질케어용 조성물 및 피부진정용 조성물을 상기 에멀젼 조성물과 각각 분리된 상태로 더 포함하는 특징을 가질 수 있다. The mask pack may further include a composition for keratinocare care and a composition for skin cleansing separately from the emulsion composition.

상기 마스크팩은 상기 각질케어용 조성물은 필링용(Peelling) 패드에 함침되고; 피부진정용 조성물은 소프트 패드에 함침되며; 에멀젼 조성물은 마스크 패드에 함침되어 각각 분리된 상태로 밀봉되어 포함되는 특징을 가질 수 있다.Wherein the mask pack is impregnated with a peeling pad for the keratin care composition; The composition for skin soothing is impregnated with a soft pad; The emulsion composition may have the feature that it is impregnated into the mask pad and sealed separately and contained.

본 발명의 마스크팩은 일주일에 단 1회의 사용만으로도 우수한 피부보습, 항산화, 미백, 및 주름개선의 효과를 제공한다. The mask pack of the present invention provides excellent skin moisturizing, antioxidant, whitening, and wrinkle-improving effects by only one use per week.

도 1은 본 발명의 각질케어용 조성물을 함침시키는 필링용(Peelling) 패드(a), 피부진정용 조성물을 함침시키는 소프트 패드(b), 에멀젼 조성물을 함침시키는 마스크 패드(c)를 도시한 사진이다.
도 2는 본 발명의 마스크팩의 구성을 나타낸 사진이다.
FIG. 1 is a photograph showing a peeling pad (a) for impregnating the composition for keratin care of the present invention, a soft pad (b) for impregnating the skin soothing composition, and a mask pad (c) for impregnating the emulsion composition to be.
2 is a photograph showing the structure of the mask pack of the present invention.

이하에서 본 발명을 자세하게 설명한다. Hereinafter, the present invention will be described in detail.

본 발명은 글리세린 1~8 중량%, 소듐하이알루로네이트 1~5 중량%, 복숭아추출물 1~7 중량%, 감초추출물 0.5~4 중량%, 소듐아세틸레이티드하이알루로네이트 1~8 중량%, 하이드롤라이즈드하이알루로닉애씨드 0.1~2 중량%, 하이드롤라이즈드콜라겐 0.1~3 중량%, 레몬추출물 0.1~3 중량%, 설탕 0.1~3 중량%, 단풍추출물 0.1~3 중량%, 빌베리열매 및 잎추출물 0.1~3 중량%, 사탕수수추출물 0.1~3 중량%, 오렌지추출물 0.1~3 중량%, 마치현추출물 0.1~3 중량%, 티트리잎추출물 0.1~3 중량%, 베르가못잎추출물 0.1~3 중량%, 대나무수 0.1~3 중량%, 동백꽃추출물 0.1~3 중량%, 판테놀디포타슘글리시리제이트 0.1~3 중량%, 알란토인 0.1~3 중량%, 베타인글리세릴아크릴레이트/아크릴릭애씨드 코폴리머 0.1~3 중량%, 피브이엠/엠에이 코폴리머 0.1~3 중량%, 프로필렌글라이콜 1~7 중량%, 하이드록시에칠아크릴레이트/소듐아크릴로일디메칠타우레이트 코폴리머 0.1~3 중량%, 잔탄검 0.01~0.3 중량%, 피이지-60 하이드로제네이티드캐스터오일 0.05~2 중량%, 1,2-핵산디올 0.1~1 중량%, 하이드록시아세토페논 0.1~1 중량%, 디소듐이디티에이 0.005~0.1 중량%, 향료 0.01~0.2 중량%, 및 정제수 잔량을 포함하는 에멀젼 조성물을 포함하는 마스크팩을 제공한다.The present invention relates to a method for producing a herbal composition comprising 1 to 8 wt% of glycerin, 1 to 5 wt% of sodium hyaluronate, 1 to 7 wt% of peach extract, 0.5 to 4 wt% of licorice extract, 1 to 8 wt% of sodium acetylated hyaluronate, 0.1 to 3% by weight of hydrolyzed collagen, 0.1 to 3% by weight of lemon extract, 0.1 to 3% by weight of sugar, 0.1 to 3% by weight of leaf extract, 0.1 to 3% by weight of the extracts of bilberry and leaf, 0.1 to 3% by weight of sugar cane extract, 0.1 to 3% by weight of orange extract, 0.1 to 3% 0.1 to 3% by weight of panthenol dipotassium glycyrrhizinate, 0.1 to 3% by weight of allantoin, 0.1 to 3% by weight of bamboo water, 0.1 to 3% 0.1 to 3% by weight of a polymer, 0.1 to 3% by weight of a PVEM / MEA copolymer, 1 to 7% by weight of propylene glycol, 0.1 to 3% by weight of sodium acryloyldimethyltaurate copolymer, 0.01 to 0.3% by weight of xanthan gum, 0.05 to 2% by weight of hydrogenated castor oil, 0.1 to 1% by weight of 1,2- , 0.1 to 1% by weight of hydroxyacetophenone, 0.005 to 0.1% by weight of disodium iodide, 0.01 to 0.2% by weight of fragrance, and a purified water balance.

상기 마스크팩은 1주일에 한번 사용으로 피부보습, 미백, 주름개선에 매우 우수한 효과를 제공한다.The use of the mask pack once a week provides excellent effects for skin moisturizing, whitening, and wrinkle improvement.

상기 성분들 중 복숭아추출물은 수분공급 및 피부광체를 부여하는 기능을 수행한다.Among these components, the peach extract performs a function of supplying water and imparting a skin light body.

상기 성분들 중 감초추출물은 피부진정에 우수한 효과를 제공한다.Licorice extracts among the above ingredients provide an excellent effect on skin soothing.

상기 성분들 중 히알루론산은 피부보습에 우수한 효과를 제공한다.Among these components, hyaluronic acid provides excellent effects on skin moisturization.

상기 성분들 중 레몬추출물은 피부생기를 개선시키는 기능을 수행한다.Among these ingredients, the lemon extract functions to improve skin vitality.

상기 성분들 중 빌베리추출물은 피부에 영양을 공급하는 기능을 수행한다.Among these ingredients, the bilberry extract performs a function of supplying nutrition to the skin.

상기 성분들 중 사탕수수추출물은 피부톤을 케어하는 기능을 수행한다.The sugar cane extract of the above components performs the function of curing the skin tone.

상기 성분들 중 오랜지추출물은 피부생기를 개선시키는 기능을 수행한다.Among these components, the orange extract functions to improve skin vitality.

상기 성분들 중 마치현추출물은 피부톤을 케어하는 기능을 수행한다.The marigold extract of the above components performs the function of curing skin tone.

상기 성분들 중 티트리잎추출물은 피부진정 기능을 수행한다.The tea tree leaf extract among the above components performs a skin soothing function.

본 발명의 마스크팩에서 상기 에멀젼 조성물은 왕겨, 율피, 메밀껍질, 및 껍질 채로 건조한 작두콩을 1~3 : 1~3 : 1~3 : 1~3의 중량비로 혼합한 혼합물을 열수추출한 추출물 0.1~5 중량%를 더 포함할 수 있다.In the mask pack of the present invention, the emulsion composition is prepared by subjecting a mixture obtained by mixing rice hull, hull, buckwheat husk and peeled dried soybeans at a weight ratio of 1: 3: 1 to 3: 1 to 3: 5% by weight.

상기 왕겨, 율피, 메밀껍질, 및 껍질 채로 건조한 작두콩은 곡물 또는 열매의 껍질로서 약효성분으로서는 많이 사용되지 않고 버려지고 있으나, 본 발명자들의 연구에 의하면 피부보호에 우수한 효과를 제공하는 것으로 확인되었다.The rice hull, hull, buckwheat husk, and husked dried soybean hulls have been found to be grains or fruit husks and are not widely used as active ingredients, but are discarded.

상기 왕겨에는 조섬유가 35~46%, 가용성 당질이 22~5%, 회분이 13~21%, 조단백질이 2~3% 포함되어 있다. 상기 율피는 소화개선과 피부노화 방지에 도움이 된다고 알려져 있다. 상기 메밀껍질은 피를 맑게 해주기 때문에 피부트러블을 방지해주는 기능을 후 수행할 수 있다.The rice husk contains 35 to 46% of crude fiber, 22 to 5% of soluble saccharide, 13 to 21% of ash, and 2 to 3% of crude protein. It is known that the urine is useful for improving digestion and preventing skin aging. Since the buckwheat husk clears the blood, it can perform the function of preventing the skin trouble.

상기 껍질 채로 건조한 작두콩은 본초강목에서 장과 위를 보호 하고 속을 따뜻하게 하고 신장기능을 강화하고 원기를 보호하고 종기나 치질 화농성 염증 질환에 효과가 있다고 언급되어 있다. 작두콩은 맛이 달고 그 성질은 따뜻하며, 비염, 알레르기성 비염, 감기, 축농증, 콧물, 재채기, 코막힘, 천식 등의 호흡기 질환에 효가가 탁월한 것으로 알려져 있다. 이 밖에 성장촉진을 시키고 뼈를 튼튼하게 할 수 있으므로 어린이 성장에 도움이 되며, 아토피, 여드름, 피부 보습 효과 때문에 피부질환에도 효과가 좋으며, 노폐물을 제거해 변비와 비만에 도움을 주고 장운동을 활발하게 해주며, 헛배부름 등의 증상에 좋다. 또한, 간이나 종기 등에 대한 염증에 탁월하고 구강염 중이염 등에도 좋으며, 혈액순환을 촉진시켜 주며, 면역력을 강화시키고, 체내 독소 배출 및 독성 해독 작용을 갖는 것으로 알려져 있다.The above-mentioned peeled dried soybeans are said to protect the intestines and stomachs in the main herbaceous gland, warm the genus, enhance the kidney function, protect the epidermis, and have an effect on boils and hemorrhagic inflammatory diseases. It is known that soybean is excellent for respiratory diseases such as rhinitis, allergic rhinitis, cold, sinusitis, runny nose, sneezing, nasal obstruction and asthma. In addition, it can stimulate growth and strengthens bones, so it helps to grow children. It is effective against skin diseases because of atopy, acne and skin moisturizing effect. It removes wastes and helps constipation and obesity, And it is good for symptom such as sloppy call. In addition, it is excellent for inflammation of liver and boil, and is good for oral mucositis, etc. It is known that it promotes blood circulation, strengthens immunity, excretes toxins in the body and detoxifies.

상기 에멀젼 조성물은 유화보조제로서 하기 화학식 1로 표시되는 화합물을 더 포함하는 특징을 가질 수 있다:The emulsion composition may have a characteristic further comprising a compound represented by the following formula (1) as an emulsifying aid:

[화학식 1][Chemical Formula 1]

Figure 112017131383810-pat00002
Figure 112017131383810-pat00002

상기 식에서,In this formula,

n은 2~10의 자연수이고,n is a natural number of 2 to 10,

a 및 b는 몰분율으로서 a는 0.5 및 b는 0.5이며;a and b are molar fractions, a is 0.5 and b is 0.5;

c 및 d는 몰분율으로서, c는 0.05~0.2이며, d는 0.8~0.95이며, c+d는 1이다.c and d are mole fractions, c is 0.05 to 0.2, d is 0.8 to 0.95, and c + d is 1.

상기 유화보조제인 폴리-D,L-락트산-co-글리콜산과 디이소시아네이트 화합물로 치환된 폴리아크릴산의 블록 공중합체에 있어서, 폴리-D,L-락트산-co-글리콜산은 소수성 부분으로 포함되며, 디이소시아네이트 화합물로 치환된 폴리아크릴산은 친수성 부분으로 포함된다.In the block copolymer of poly-D, L-lactic acid-co-glycolic acid and polyacrylic acid substituted with a diisocyanate compound as the emulsifying aid, poly-D, L-lactic acid-co- glycolic acid is included as a hydrophobic part, Polyacrylic acid substituted with an isocyanate compound is included as a hydrophilic moiety.

상기에서 폴리-D,L-락트산-co-글리콜산(하기 화학식 2)과 디이소시아네이트 화합물로 치환된 폴리아크릴산(하기 화학식 3)은 이소시아네이트기와 카르복실기의 히드록시기의 결합에 의해 폴리-D,L-락트산-co-글리콜산과 디이소시아네이트 화합물로 치환된 폴리아크릴산의 블록 공중합체를 형성한다.In the above, polyacrylic acid substituted by poly-D, L-lactic acid-co-glycolic acid (Formula 2) and diisocyanate compound (Formula 3 below) can be produced by the combination of an isocyanate group and a hydroxyl group of a carboxyl group. a block copolymer of polyacrylic acid substituted with -co-glycolic acid and diisocyanate compound is formed.

[화학식 2](2)

Figure 112017131383810-pat00003
Figure 112017131383810-pat00003

[화학식 3](3)

Figure 112017131383810-pat00004
Figure 112017131383810-pat00004

상기 폴리-D,L-락트산-co-글리콜산의 중량 평균분자량은 1,000 내지 80,000인 것이 바람직하며, 상기 디이소시아네이트 화합물로 치환된 폴리아크릴산의 공중합체의 중량평균분자량은 100 내지 10,000인 것을 사용하는 것이 나노입자 에멀션의 형성에 바람직하다.The poly-D, L-lactic acid-co-glycolic acid preferably has a weight average molecular weight of 1,000 to 80,000, and the copolymer of polyacrylic acid substituted with the diisocyanate compound has a weight average molecular weight of 100 to 10,000. Are preferred for the formation of nanoparticle emulsions.

상기 공중합체의 평균 입자 직경은 10 내지 1,00 나노미터인 것이 바람직하다. 이러한 입자크기일 때 피부로의 침투 및 유효성분의 포집성이 우수하게 된다. 이와 같이 얻어지는 공중합체는 저분자량 미셀과 비교하여 수용액 속에서 현저하게 안정적이다. 상기 공중합체의 이러한 특징은 본 발명의 수중유형 나노입자 에멀션 화장료 조성물이 장기간 동안 안정된 상태로 보관될 수 있으며, 체내에서도 상당한 기간동안 그 구조를 유지할 수 있음을 의미한다.The average particle diameter of the copolymer is preferably from 10 to 100 nm. When such a particle size is used, penetration into the skin and collection of the active ingredient are excellent. The thus obtained copolymer is remarkably stable in an aqueous solution as compared with a low molecular weight micelle. This characteristic of the copolymer means that the water-in-oil type nanoparticulate emulsion cosmetic composition of the present invention can be stored in a stable state for a long period of time and can maintain its structure for a considerable period of time in the body.

본 발명의 에멀젼 조성물은 나노에멀젼 내상의 함량을 높이고 유효성분을 효과적으로 전달하기 위해 목적하는 분산성을 달성할 수 있는 정도의 저점도를 가지는 것이라면 특별히 제한되지 않으나, 예를 들어 5000 cps 이하, 구체적으로 3000 cps 이하, 더욱 구체적으로 2000 cps 이하의 점도를 가질 수 있다. 상기 '저점도'의 에멀젼은 점도가 매우 작아 점도를 실험적으로 측정할 수 없는 경우에서부터 앞서 언급한 점도 범위에 속하는 에멀젼 모두를 포함하는 것으로, 점도가 실험적으로 측정되지 않은 경우의 점도 범위는 0이므로, 예를 들어 0 내지 5000cps, 구체적으로 1 내지 3000 cps, 더욱 구체적으로 5 내지 2000 cps의 점도를 가질 수 있다.The emulsion composition of the present invention is not particularly limited as long as it has a low viscosity to such an extent that the desired dispersibility can be achieved in order to increase the content of the nanoemulsion inner layer and effectively deliver the active ingredient. For example, the emulsion composition may have a viscosity of 5000 cps or less, 3000 cps or less, more specifically 2000 cps or less. The 'low viscosity' emulsion contains all of the emulsions belonging to the aforementioned viscosity ranges from when the viscosity can not be measured experimentally because the viscosity is very small. When the viscosity is not experimentally measured, the viscosity range is 0 , For example from 0 to 5000 cps, specifically from 1 to 3000 cps, more specifically from 5 to 2000 cps.

상기 에멀젼은 나노 크기를 가지는 것으로 에멀젼의 안정도를 향상시키면서도 저점도의 에멀젼을 제조할 수 있을 정도라면 특별히 제한되지 않으나, 예를 들어 평균 크기가 250 nm 이하, 구체적으로 200 nm 이하일 수 있다.The emulsion is nano-sized and is not particularly limited as long as it can produce an emulsion having a low viscosity while improving the stability of the emulsion. For example, the emulsion may have an average size of 250 nm or less, specifically 200 nm or less.

상기 에멀젼은 위 평균 크기 범위에 속하는 어떠한 크기라도 가질 수 있으나, 예를 들어 10 내지 250 nm, 구체적으로 20 내지 200 nm의 평균 크기를 가질 수 있다. The emulsion may have any size falling within the above average size range, but may have an average size of, for example, 10 to 250 nm, specifically 20 to 200 nm.

본 발명의 마스크팩은 각질케어용 조성물 및 피부진정용 조성물을 상기 에멀젼 조성물과 각각 분리된 상태로 더 포함할 수 있다. The mask pack of the present invention may further comprise a composition for keratin care and a composition for skin soothing, separately from the emulsion composition.

상기 각질케어용 조성물은 글리세린 1~8 중량%, 소듐하이알루로네이트 1~5 중량%, 메칠프로판디올변성알코올 0.5~4 중량%, 복숭아추출물 1~7 중량%, 감초추출물 0.5~4 중량%, 소듐아세틸레이티드하이알루로네이트 1~8 중량%, 하이드롤라이즈드하이알루로닉애씨드 0.1~2 중량%, 하이드롤라이즈드콜라겐 0.1~3 중량%, 레몬추출물 0.1~3 중량%, 설탕 0.1~3 중량%, 단풍추출물 0.1~3 중량%, 빌베리열매 및 잎추출물 0.1~3 중량%, 사탕수수추출물 0.1~3 중량%, 오렌지추출물 0.1~3 중량%, 마치현추출물 0.1~3 중량%, 티트리잎추출물 0.1~3 중량%, 락토바이오닉애씨드 0.1~3 중량%, 소듐락테이트, 0.1~3 중량%, 글라이콜릭애씨드 0.1~3 중량%, 디포타슘글리시리제이트 0.1~3 중량%, 알란토인 0.1~3 중량%, 피이지-60 하이드로제네이티드캐스터오일 0.05~2 중량%, 1,2-핵산디올 0.1~1 중량%, 하이드록시아세토페논 0.1~1 중량%, 디소듐이디티에이 0.005~0.1 중량%, 향료 0.01~0.2 중량%, 및 정제수 잔량을 포함하는 것이 바람직하며;Wherein the composition for keratin care comprises 1 to 8 wt% of glycerin, 1 to 5 wt% of sodium hyaluronate, 0.5 to 4 wt% of methylpropanediol-modified alcohol, 1 to 7 wt% of peach extract, 0.5 to 4 wt% 1 to 8% by weight of sodium acetylated hyaluronate, 0.1 to 2% by weight of hydrolized hyaluronic acid, 0.1 to 3% by weight of hydrolized collagen, 0.1 to 3% by weight of lemon extract, 0.1 to 3% by weight of the leaves extract, 0.1 to 3% by weight of the leaves extract, 0.1 to 3% by weight of the extract of Bilberry fruit and leaf, 0.1 to 3% by weight of sugar cane extract, 0.1 to 3% 0.1 to 3 wt% of tea tree leaf extract, 0.1 to 3 wt% of lactobionic acid, 0.1 to 3 wt% of sodium lactate, 0.1 to 3 wt% of glycolic acid, 0.1 to 3 wt% of dipotassium glycyrrhizate, 0.1 to 3% by weight of allantoin, 0.05 to 2% by weight of a fat-60 hydrogenated castor oil, 0.1 to 1% by weight of a 1,2-nucleic acid diol, Non 0.1-1 wt.%, Disodium is preferred to include this in a dithiol 0.005 ~ 0.1% by weight, 0.01% to 0.2% by weight perfume, and the remaining amount of purified water, and;

상기 피부진정용 조성물은 메칠프로판디올글리세린 1~8 중량%, 소듐하이알루로네이트 1~5 중량%, 복숭아추출물 1~7 중량%, 감초추출물 0.5~4 중량%, 소듐아세틸레이티드하이알루로네이트 1~8 중량%, 하이드롤라이즈드하이알루로닉애씨드 0.1~2 중량%, 하이드롤라이즈드콜라겐 0.1~3 중량%, 레몬추출물 0.1~3 중량%, 설탕 0.1~3 중량%, 단풍추출물 0.1~3 중량%, 빌베리열매 및 잎추출물 0.1~3 중량%, 사탕수수추출물 0.1~3 중량%, 오렌지추출물 0.1~3 중량%, 마치현추출물 0.1~3 중량%, 티트리잎추출물 0.1~3 중량%, 베르가못잎추출물 0.1~3 중량%, 대나무수 0.1~3 중량%, 동백꽃추출물 0.1~3 중량%, 판테놀디포타슘글리시리제이트 0.1~3 중량%, 알란토인 0.1~3 중량%, 하이드록시에칠셀룰로오스 0.1~3 중량%, 글리세릴폴리아크릴레이트 0.1~3 중량%, 시트릭애씨드 0.1~3 중량%, 소듐시트레이트 0.1~3 중량%, 피이지-60 하이드로제네이티드캐스터오일 0.05~2 중량%, 1,2-핵산디올 0.1~1 중량%, 하이드록시아세토페논 0.1~1 중량%, 디소듐이디티에이 0.005~0.1 중량%, 향료 0.01~0.2 중량%, 및 정제수 잔량을 포함하는 것이 바람직하다. Wherein the skin-soothing composition comprises 1 to 8% by weight of methylpropanediol glycerin, 1 to 5% by weight of sodium hyaluronate, 1 to 7% by weight of peach extract, 0.5 to 4% by weight of licorice extract, sodium acetylated hyaluronic acid 0.1 to 3% by weight of hydrolyzed collagen, 0.1 to 3% by weight of lemon extract, 0.1 to 3% by weight of sugar, 0.1 to 3% by weight of the extracts of Bilberry fruit and leaf extract, 0.1 to 3% by weight of sugar extract, 0.1 to 3% by weight of orange juice extract, 0.1 to 3% 0.1 to 3% by weight of bergamot leaf extract, 0.1 to 3% by weight of bamboo water, 0.1 to 3% by weight of camphor flower extract, 0.1 to 3% by weight of panthenol dipotassium glycyrrhizate, 0.1 to 3% by weight of allantoin, 0.1 to 3% by weight of fumed cellulose, 0.1 to 3% by weight of glyceryl polyacrylate, 0.1 to 3% by weight of citric acid, 0.1 to 3% 0.1 to 1% by weight of 1,2-nucleic acid diol, 0.1 to 1% by weight of hydroxyacetophenone, 0.005 to 0.1% by weight of disodium dipentaerythritol, 0.05 to 2% by weight of hydrogenated castor oil, 0.01 to 0.2% by weight of a perfume, and a purified water balance.

본 발명의 마스크팩에서, 상기 각질케어용 조성물은 도 1에 도시된 바와 같은 필링용(Peelling) 패드에 함침되고; 피부진정용 조성물은 소프트 패드에 함침되며; 에멀젼 조성물은 마스크 패드에 함침되어 각각 분리된 상태로 밀봉되어 포함될 수 있다. In the mask pack of the present invention, the composition for keratin care is impregnated with a peeling pad as shown in Fig. 1; The composition for skin soothing is impregnated with a soft pad; The emulsion composition may be impregnated into the mask pads and sealed and contained separately.

상기 필링용(Peelling) 패드, 소프트 패드, 및 마스크 패드의 소재로는 이 분야에 공지된 것이 제한 없이 사용될 수 있으며, 특별히 한정되지 않는다. 예를 들어 필링용 패트는 도 1에 도시된 바와 같이 표면이 촘촘한 부직포 형태가 사용될 수 있고, 소프트 패드로는 면으로 제조된 엠보싱면을 갖는 패드가 사용될 수 있다. The material for the peeling pad, the soft pad, and the mask pad may be any material known in the art without limitation. For example, the pad for peeling may be a nonwoven fabric having a fine surface as shown in Fig. 1, and as the soft pad, a pad having an embossed surface made of a surface may be used.

본 발명의 마스크팩은 각질케어용 조성물이 함침된 필링용(Peelling) 패드; 피부진정용 조성물이 함침된 소프트 패드; 및 에멀젼 조성물이 함침된 마스크 패드가 각각 독립적으로 밀봉 포장되고, 하나의 밀봉팩에 포장되는 형태를 가질 수 있다. The mask pack of the present invention comprises: a peeling pad impregnated with a composition for keratin care; A soft pad impregnated with a composition for skin soothing; And the mask pads impregnated with the emulsion composition are each sealed individually and packaged in one sealed pack.

이들의 사용방법은 각질케어, 피부진정, 및 보습 마스크 패드의 피부밀착 방식으로 공지된 방법들에 따라 사용될 수 있다. Their methods of use can be used according to known methods for keratinic care, skin soothing, and the skin contact method of a moisturizing mask pad.

이하에서, 실시예를 통하여 본 발명을 보다 상세히 설명한다. 그러나, 하기의 실시예는 본 발명을 더욱 구체적으로 설명하기 위한 것으로서, 본 발명의 범위가 하기의 실시예에 의하여 한정되는 것은 아니다. 하기의 실시예는 본 발명의 범위 내에서 당업자에 의해 적절히 수정, 변경될 수 있다. Hereinafter, the present invention will be described in more detail by way of examples. However, the following examples are intended to further illustrate the present invention, and the scope of the present invention is not limited by the following examples. The following examples can be appropriately modified and changed by those skilled in the art within the scope of the present invention.

제조예Manufacturing example 1: 왕겨,  1: chaff, 율피Julie , 메밀껍질, 및 , Buckwheat husks, and 껍질 채로Peeled 건조한 작두콩의  Arid soybean 열수추출물Hot water extract 제조 Produce

왕겨, 율피, 메밀껍질, 및 껍질 채로 건조한 작두콩을 각각 300g 씩 혼합하고, 증류수 12 리터에 넣고, 100℃에서 24시간 추출하여 열수 추출물을 제조하였다. Rice hull, husk, buckwheat husks, and peanut dried soybeans were mixed in an amount of 300 g each, put into 12 liters of distilled water, and extracted at 100 ° C for 24 hours to prepare a hot water extract.

제조예Manufacturing example 2:  2: 폴리Poly -- D,LD, L -락트산-co-- lactic acid-co- 글리콜산과Glycolic acid 디이소시아네이트Diisocyanate 화합물로 치환된  Substituted with a compound 폴리아크릴산의Of polyacrylic acid 블록 공중합체의 제조 Preparation of block copolymers

(1) 디이소시아네이트 화합물로 치환된 폴리아크릴산의 제조(1) Preparation of polyacrylic acid substituted with diisocyanate compound

질소 가스가 환류되고, 온도 조절이 용이하도록 냉각 장치를 설치한 1L 반응기에 아크릴산 40 중량부를 투입하였다. 에틸 아세테이트(EAc; ethyl aceate) 60 중량부를 용제로 투입하고, 질소 가스를 30분 동안 퍼징(purging)하였다. 온도를 60℃로 유지하고, 반응개시제인 AIBN(azobisisobutyronitrile) 0.1 중량부를 투입하고, 3 시간 동안 반응시켜, 중량평균분자량이 1,500인 아크릴산 중합체를 제조하였다.40 parts by weight of acrylic acid was added to a 1 L reactor equipped with a cooling device so that nitrogen gas was refluxed and the temperature thereof was easily controlled. 60 parts by weight of ethyl acetate (EAc; ethyl acetate) was poured into the solvent, and nitrogen gas was purged for 30 minutes. The temperature was maintained at 60 占 폚 and 0.1 part by weight of AIBN (azobisisobutyronitrile) as a reaction initiator was added and reacted for 3 hours to prepare an acrylic acid polymer having a weight average molecular weight of 1,500.

질소 가스가 환류되고, 온도 조절이 용이하도록 냉각 장치를 설치한 1L 반응기에, 에틸 아세테이트(EAc; ethyl aceate) 100 중량부를 용제로 투입하고 상기에서 제조된 아크릴산 중합체 고형분 100중량부와, 헥사메틸렌디이소시아네이트 10중량부 및 마그네슘 트리플루오로술포네이트 54 mg 및 로놀(lonol) 0.5 중량부와 티누빈(Tinuvin) 0.15 중량부를 투입하였다. 110℃까지 가열하였다. 가열을 15시간 동안 수행하여 헥사메틸렌디이소시아네이트로 치환된 아크릴산을 제조하였다. 100 parts by weight of ethyl acetate (EAc; ethyl aceate) was added to a 1 L reactor equipped with a cooling device to easily regulate the temperature of the reflux of the nitrogen gas. 100 parts by weight of the acrylic acid polymer solid component prepared above and 100 parts by weight of hexamethylene di 10 parts by weight of isocyanate, 54 mg of magnesium trifluorosulfonate, 0.5 part by weight of lonol and 0.15 part by weight of Tinuvin were added. And heated to 110 deg. Heating was carried out for 15 hours to prepare acrylic acid substituted with hexamethylene diisocyanate.

(2) 폴리-D,L-락트산-co-글리콜산과 디이소시아네이트 화합물로 치환된 폴리아크릴산의 블록 공중합체의 제조(2) Preparation of block copolymer of poly-D, L-lactic acid-co-glycolic acid and polyacrylic acid substituted with diisocyanate compound

반응 용기에 디메틸포름아마이드 100 ml 및 N,N-카르보닐디이미다졸(N,N- carbonyldiimidazole, CDI) 290 mg을 넣고 교반하였다. 여기에 수평균분자량 11,000의 폴리-D,L-락트산-co-글리콜산(RG502, 베링거잉겔하임, 독일) 20 g을 첨가하여 폴리-D,L-락트산-co-글리콜산의 하이드록시 말단기를 활성화시켰다. 상기 용액에 로놀(lonol) 0.5 mg과 티누빈(Tinuvin) 0.15mg과 상기 제조예 1에서 제조된 수평균 분자량이 2,000인 폴리아크릴산 25g을 가하고 110℃까지 가열하였다. 가열을 15시간 동안 수행한 후, 0.45 마이크로미터의 공극 크기를 지닌 나일론 필터로 여과시킨 뒤, 삼차증류수에 분산시킨 뒤 투석을 통해 미반응물 및 반응시약을 제거하여 블록공중합체를 제조하였다. 100 ml of dimethylformamide and 290 mg of N, N-carbonyldiimidazole (CDI) were added to the reaction vessel and stirred. To this was added 20 g of poly-D, L-lactic acid-co-glycolic acid (RG502, Boehringer Ingelheim, Germany) having a number average molecular weight of 11,000 to obtain a hydroxyaldehyde group of poly-D, L-lactic acid- Lt; / RTI > 0.5 mg of lonol, 0.15 mg of Tinuvin and 25 g of polyacrylic acid having a number average molecular weight of 2,000 prepared in Preparation Example 1 were added to the solution and heated to 110 ° C. The mixture was heated for 15 hours, filtered through a nylon filter having a pore size of 0.45 micrometer, dispersed in tertiary distilled water, and then dialyzed to remove unreacted materials and reaction reagents to prepare a block copolymer.

실시예Example 1:  One: 에멀젼emulsion 조성물의 제조 Preparation of composition

하기 표 1에 기재된 조성에 따라 각 성분을 유상과 수상으로 나누어 각각 70 ~ 90℃로 가열한 후에, 유상을 수상에 첨가하여 호모믹서로 교반하는 유화방법으로 O/W 에멀젼을 제조하였다.Each component was divided into oil phase and water phase according to the composition shown in the following Table 1, heated to 70 to 90 占 폚, and then an oil phase was added to the water phase and stirred with a homomixer to prepare an O / W emulsion.

성분ingredient 함량(중량%)Content (% by weight) 글리세린glycerin 55 소듐하이알루로네이트Sodium hyaluronate 33 복숭아추출물Peach extract 44 감초추출물Licorice extract 22 소듐아세틸레이티드하이알루로네이트Sodium acetylated hyaluronate 44 하이드롤라이즈드하이알루로닉애씨드Hydrolyzed hyaluronic acid 0.50.5 하이드롤라이즈드콜라겐Hydrolized Collagen 1One 레몬추출물Lemon extract 1One 설탕Sugar 0.50.5 단풍추출물Maple extract 0.50.5 빌베리열매 및 잎추출물Bilberry fruit and leaf extract 0.50.5 사탕수수추출물Sugar cane extract 1One 오렌지추출물Orange extract 1One 마치현추출물Marchia extract 22 티트리잎추출물Tea tree leaf extract 0.50.5 베르가못잎추출물Bergamot leaf extract 0.50.5 대나무수Bamboo water 1One 동백꽃추출물Camellia extract 0.50.5 판테놀디포타슘글리시리제이트Panthenol dipotassium glycyrrhizate 1One 알란토인Allantoin 0.50.5 베타인글리세릴아크릴레이트/아크릴릭애씨드 코폴리머Betaine glyceryl acrylate / acrylic acid copolymer 1One 피브이엠/엠에이 코폴리머PVEM / MEG copolymer 1One 프로필렌글라이콜Propylene glycol 22 하이드록시에칠아크릴레이트/소듐아크릴로일디메칠타우레이트 코폴리머Hydroxyethyl methacrylate / sodium acryloyldimethyltaurate copolymer 1One 잔탄검Xanthan gum 0.060.06 피이지-60 하이드로제네이티드캐스터오일PIGGY-60 Hydrogenated Castor Oil 0.20.2 1,2-핵산디올1,2-nucleic acid diol 0.40.4 하이드록시아세토페논Hydroxyacetophenone 0.30.3 디소듐이디티에이Disodium iodide 0.20.2 향료Spices 0.040.04 정제수Purified water 잔량Balance 합계Sum 100100

실시예Example 2:  2: 에멀젼emulsion 조성물의 제조 Preparation of composition

상기 실시예 1의 조성에 상기 제조예 2에서 제조된 화학식 1로 표시되는 유화보조제 3 중량%를 더 혼합하고 실시예 1과 동일한 방법으로 에멀젼 조성물을 제조하였다.An emulsion composition was prepared in the same manner as in Example 1 except that 3% by weight of the emulsifying auxiliary represented by the formula (1) prepared in Preparation Example 2 was further added to the composition of Example 1 above.

실시예Example 3  3 각질케어용For Keratin Care 조성물의 제조 Preparation of composition

하기 표 2에 기재된 조성에 따라 각 성분을 혼합하여 각질케어용 조성물을 제조하였다.Each component was mixed according to the composition shown in Table 2 below to prepare a composition for keratin care.

성분ingredient 함량(중량%)Content (% by weight) 글리세린glycerin 55 소듐하이알루로네이트Sodium hyaluronate 33 메칠프로판디올변성알코올Methylpropane diol denatured alcohol 22 복숭아추출물Peach extract 44 감초추출물Licorice extract 22 소듐아세틸레이티드하이알루로네이트Sodium acetylated hyaluronate 44 하이드롤라이즈드하이알루로닉애씨드Hydrolyzed hyaluronic acid 0.50.5 하이드롤라이즈드콜라겐Hydrolized Collagen 1One 레몬추출물Lemon extract 1One 설탕Sugar 0.50.5 단풍추출물Maple extract 0.50.5 빌베리열매 및 잎추출물Bilberry fruit and leaf extract 0.50.5 사탕수수추출물Sugar cane extract 1One 오렌지추출물Orange extract 1One 마치현추출물Marchia extract 22 티트리잎추출물Tea tree leaf extract 0.50.5 락토바이오닉애씨드Lactobionic Acid 0.50.5 소듐락테이트, Sodium lactate, 1One 글라이콜릭애씨드, Glycolic acid, 0.50.5 디포타슘글리시리제이트Dipotassium glycyrrhizate 1One 알란토인Allantoin 0.50.5 피이지-60 하이드로제네이티드캐스터오일PIGGY-60 Hydrogenated Castor Oil 0.20.2 1,2-핵산디올1,2-nucleic acid diol 0.40.4 하이드록시아세토페논Hydroxyacetophenone 0.30.3 디소듐이디티에이Disodium iodide 0.20.2 향료Spices 0.040.04 정제수Purified water 잔량Balance 합계Sum 100100

실시예Example 4:  4: 피부진정용For soothing skin 조성물의 제조 Preparation of composition

하기 표 3에 기재된 조성에 따라 각 성분을 혼합하여 피부진정용 조성물을 제조하였다.Each component was mixed according to the composition shown in Table 3 below to prepare a composition for skin soothing.

성분ingredient 함량(중량%)Content (% by weight) 메칠프로판디올글리세린Methylpropanediol glycerin 55 소듐하이알루로네이트Sodium hyaluronate 33 복숭아추출물Peach extract 44 감초추출물Licorice extract 22 소듐아세틸레이티드하이알루로네이트Sodium acetylated hyaluronate 44 하이드롤라이즈드하이알루로닉애씨드Hydrolyzed hyaluronic acid 0.50.5 하이드롤라이즈드콜라겐Hydrolized Collagen 1One 레몬추출물Lemon extract 1One 설탕Sugar 0.50.5 단풍추출물Maple extract 0.50.5 빌베리열매 및 잎추출물Bilberry fruit and leaf extract 0.50.5 사탕수수추출물Sugar cane extract 1One 오렌지추출물Orange extract 1One 마치현추출물Marchia extract 22 티트리잎추출물Tea tree leaf extract 0.50.5 베르가못잎추출물Bergamot leaf extract 0.50.5 대나무수Bamboo water 1One 동백꽃추출물Camellia extract 0.50.5 판테놀디포타슘글리시리제이트Panthenol dipotassium glycyrrhizate 1One 알란토인Allantoin 0.50.5 하이드록시에칠셀룰로오스Hydroxyethyl cellulose 1One 글리세릴폴리아크릴레이트Glyceryl polyacrylate 0.50.5 시트릭애씨드 Citric acid 1One 소듐시트레이트Sodium citrate 0.50.5 피이지-60 하이드로제네이티드캐스터오일PIGGY-60 Hydrogenated Castor Oil 0.20.2 1,2-핵산디올1,2-nucleic acid diol 0.40.4 하이드록시아세토페논Hydroxyacetophenone 0.30.3 디소듐이디티에이Disodium iodide 0.20.2 향료Spices 0.040.04 정제수Purified water 잔량Balance 합계Sum 100100

실시예Example 5:  5: 에멀젼emulsion 함침Impregnation 마스크 패드의 제조 Manufacture of mask pads

상기 실시예 1 및 실시예 2에서 제조한 에멀젼 조성물을 각각 부직포 마스크 패드에 함침시켜서 에멀젼 함침 마스크 패드를 제조하였다. The emulsion compositions prepared in Examples 1 and 2 were immersed in a nonwoven mask pad to prepare an emulsion-impregnated mask pad.

실시예Example 6:  6: 각질케어Horny Care 필링용( For filling PeellingPeelling ) 패드의 제조) Manufacture of pads

상기 실시예 2에서 제조한 각질케어용 조성물을 부직포 필링용 패드에 함침시켜서 각질케어 필링용 패드를 제조하였다. The composition for keratinocyte care prepared in Example 2 was impregnated in a nonwoven fabric-filling pad to prepare a pad for keratin-care filling.

실시예Example 7:  7: 피부진정용For soothing skin 소프트 패드의 제조 Manufacture of soft pads

상기 실시예 3에서 제조한 피부진정용 조성물을 면직 소프트 패드에 함침시켜서 피부진정용 소프트 패드를 제조하였다. The skin-soothing composition prepared in Example 3 was impregnated with a cotton soft pad to prepare a soothing soft pad.

시험예Test Example 1:  One: 에멀젼emulsion 조성물의  Of the composition 에멀젼의Emulsion 입자 크기 측정 및 입자 크기 변화에 의한 나노에멀션 안정도 평가 Measurement of particle size and stability of nano emulsion by particle size change

동적 광산란 원리에 의한 마스터사이저 2000 (Mastersizer 2000, Malvern Instrument, UK)을 사용하여, 상기 실시예 1 및 2에 따라 얻은 본 발명의 유중수형 나노입자 에멀션 화장료 조성물들의 입자의 크기를 각각 측정하였고, 그 결과는 하기 표 4에 나타내었다. 이 때 입자 크기의 측정은 나노에멀션 희석 용액의 탁도가 10-20%가 되도록 정제수로서 희석시켜서 다음과 같은 조건하에서 실시되었다.The sizes of the particles of the water-in-oil type nanoparticle emulsion cosmetic compositions of the present invention obtained according to Examples 1 and 2 were measured using mastersizer 2000 (Mastersizer 2000, Malvern Instrument, UK) by the dynamic light scattering principle, The results are shown in Table 4 below. At this time, the measurement of the particle size was carried out under the following conditions by diluting the nano emulsion diluted solution with purified water to have a turbidity of 10-20%.

측정시간: 2분, 초당 측정 회수: 5×103, 온도: 20℃, 점도: 0.89 centipoise, 입자 굴절율: 1.4, 분산매 굴절율: 1.33Measurement time: 2 minutes, the number of measurements per second: 5 × 10 3, temperature: 20 ℃, viscosity: 0.89 centipoise, particle refractive index: 1.4, refractive index of dispersion medium: 1.33

입자 크기 측정은 제조 1일후 및 40℃에서 6개월동안 보관후 2회에 걸쳐 실시하여 고온에서 장기간 보관후의 나노에멀션의 열역학적 안정성을 평가하였다.Particle size measurements were made after one day of manufacture and after storage for 6 months at 40 ° C for two times to evaluate the thermodynamic stability of the nanoemulsion after long term storage at high temperature.

시험예Test Example 2. 육안 관찰에 의한 유화안정도 2. Stability of emulsification by visual observation

상기 실시예 1 및 실시예 2에서 얻은 유중수형 나노에멀션 화장료 조성물들의 유화안정도는 입자크기의 측정과 함께 육안으로 다음과 같이 관찰하여 평가하였고, 그 결과는 하기 표 4에 나타내었다.The emulsion stability of the water-in-oil type nano-emulsion cosmetic compositions obtained in Examples 1 and 2 was evaluated by naked eye observation and evaluation as follows. The results are shown in Table 4 below.

상기 실시예 1 및 실시예 2의 조성물을 실온(약 25℃)과 40℃에서 6개월 보관 후의 유화상태를 제조 직후의 상태와 비교 관찰하였다. 불안정한 상태는 침강, 분리, 배액, 크리밍, 합일 등이 일어난 부분으로 육안으로 관찰하였다. 유화안정도는 전체에서 불안정한 부분을 제외한 안정한 부분의 백분율(%)로서 평가하는데 다음식으로 나타낸다.The emulsified state of the composition of Example 1 and Example 2 after storage at room temperature (about 25 ° C) and at 40 ° C for 6 months was compared with the state immediately after preparation. The unstable state was observed by visual observation as sedimentation, separation, drainage, creaming, and union. The emulsion stability is evaluated as a percentage (%) of the stable part excluding the unstable part as a whole.

유화안정도(%) = [(전체-불안정한 부분)/전체]×100 %Emulsion stability (%) = [(total - unstable part) / total] × 100%

나노입자 에멀젼
화장료 조성물
Nanoparticle emulsion
Cosmetic composition
입자크기(nm)Particle Size (nm) 입자크기 증가(%)Increase in particle size (%) 육안관찰에 의한 유화안정도(%)Stability of emulsification by visual observation (%)
제조 후, 실온 1일 보관 후After the preparation, storage at room temperature for 1 day 제조 후 40℃에서 6개월 보관 후After storage for 6 months at 40 ° C 실시예 1Example 1 7979 8282 3.83.8 9494 실시예 2Example 2 7676 7878 2.62.6 9696

상기 표 4에서 확인되는 바와 같이, 본 발명의 유화안정도 조성물은 나노입자 에멀젼으로서 매우 우수한 안정성을 가지며, 특히, 화학식 1로 표시되는 유화보조제를 사용하는 경우에는 더 우수한 안정성을 나타냄을 알 수 있다.As can be seen in Table 4, the emulsion stabilizing composition of the present invention has excellent stability as a nanoparticle emulsion. In particular, when the emulsifying aid represented by the general formula (1) is used, the emulsion is more stable.

시험예Test Example 3: 피부안전성 3: Skin safety

피부 안전성은 실시예 1 내지 실시예 4에서 제조된 조성물에 대하여 피부 첩보 실험을 통하여 평가하였다. 화장품에 의한 피부 부작용을 경험한 적이 있었던 총 15명(여자: 10명, 남자: 5명)을 대상으로 환자의 등에 첩포를 도포한 후, 48시간이 지나서 첩포를 떼고 1시간 내지 2시간 후에 일차 판정을 하였으며, 72시간 혹은 96시간 후에도 판정하여 그 결과를 하기 표 5에 나타내었다.The skin safety was evaluated by skin-spiking experiments on the compositions prepared in Examples 1 to 4. 15 patients (female: 10, male: 5) who had experienced skin adverse effects due to cosmetics were applied to the back of the patient, and after 48 hours, the papilla was removed and after 1 hour to 2 hours, The results were also evaluated after 72 hours or 96 hours. The results are shown in Table 5 below.

양성 반응자 수Number of positive responders %% 실시예 1 에멀젼 조성물Example 1 [ 00 00 실시예 2 에멀젼 조성물Example 2 [ 00 00 실시예 3 에멀젼 조성물Example 3 [ 00 00 실시예 4 에멀젼 조성물Example 4 The emulsion composition 00 00

상기 표 5에 나타난 바와 같이, 본 발명의 조성물들은 피부 안전성이 매우 우수한 것을 알 수 있었다. As shown in Table 5, the compositions of the present invention have excellent skin safety.

시험예Test Example 4: 항산화 효능평가 ( 4: Antioxidative efficacy evaluation ( ABTSABTS assay 사용) assay)

1) 시료 정보1) Sample information

(1) 0.45㎛ filter로 여과 후 사용(1) Filtered with 0.45μm filter

(2) 시료준비: 실시예 1의 조성물을 10배 희석하여 사용(2) Sample preparation: The composition of Example 1 was diluted 10 times and used

2) 평가 방법2) Evaluation method

(1) 실험 재료(1) Experimental material

- ABTS(2,2'-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid)) 7mM 용액- 7 mM solution of ABTS (2,2'-azino-bis (3-ethylbenzothiazoline-6-sulphonic acid)

- Potassium persulfate(K2S2O8) 140mM 용액- Potassium persulfate (K2S2O8) 140 mM solution

- Standard solution (Ascorbic acid 80㎍/㎖, 40㎍/㎖, 20㎍/㎖, 10㎍/㎖)- Standard solution (Ascorbic acid 80 g / ml, 40 g / ml, 20 g / ml, 10 g / ml)

- 96 well plate- 96 well plate

- ELISA reader- ELISA reader

(2) 실험 순서(2) Procedure of experiments

a. ABTS+ Stock solution을 제조하여 24시간 방치 후 흡광도(734㎚) 값이 0.68~0.72가 나오도록 희석a. ABTS + Stock solution was prepared and diluted such that the absorbance (734 nm) value was 0.68 ~ 0.72 after standing for 24 hours.

b. 시료 및 standard solution을 96 well plate에 well 당 20㎕씩 첨가b. Add 20 μl of sample and standard solution to 96 well plate

c. ABTS+ Solution을 각 well 당 180㎕씩 첨가c. Add 180 μl of ABTS + solution per well

d. 암실, 실온에서 10분간 반응 후 흡광도(734㎚) 측정d. Measurement of absorbance (734 nm) after 10 min reaction at room temperature in dark room

3) 항산화 효능 평가 결과(ABTS assay)3) Antioxidant efficacy evaluation result (ABTS assay)

상기 항산화 효능평가(ABTS assay) 결과, 실시예 1의 조성물 10배 희석액은 대표적인 항산화 물질인 Ascorbic acid 40㎍/㎖과 비교하여 동등 이상의 항산화 활성을 나타냈다. As a result of the antioxidative efficacy evaluation (ABTS assay), the 10-fold dilution of the composition of Example 1 exhibited antioxidative activity equal to or higher than that of 40 μg / ml of representative antioxidant, ascorbic acid.

시험예Test Example 5: 미백 효능평가 ( 5: Evaluation of whitening efficacy ( MelanogenesisMelanogenesis inhibition assay 사용) inhibition assay)

1) 시료 정보1) Sample information

(1) 0.45㎛ filter로 여과 후 사용(1) Filtered with 0.45μm filter

(2) 시료준비: 실시예 1의 조성물을 10배로 희석하여 사용(2) Sample preparation: The composition of Example 1 was diluted 10 times and used

2) 평가 방법2) Evaluation method

(1) 실험 재료(1) Experimental material

- 멜라닌 생성 세포주 B16F10 cell (ATCC CRL-6475)- melanin-producing cell line B16F10 cell (ATCC CRL-6475)

- DMEM 배지 (+10% FBS, 1% Antibiotics)- DMEM medium (+ 10% FBS, 1% Antibiotics)

- Positive control (Arbutin 2㎎/㎖)- Positive control (Arbutin 2 mg / ml)

- 37℃ CO2 incubator- 37 ° C CO2 incubator

- PBS(Phosphate Buffered Saline) pH 7.4- PBS (Phosphate Buffered Saline) pH 7.4

- 50uM α-MSH(α-Melanocyte Stimulating Hormone) stock solution- 50 uM α-MSH (α-Melanocyte Stimulating Hormone) stock solution

- Trypsin-EDTA- Trypsin-EDTA

- 1M NaOH (+10% DMSO)- 1 M NaOH (+ 10% DMSO)

- Cell Counting Kit-8 (제조사: Dojindo)- Cell Counting Kit-8 (Manufacturer: Dojindo)

- Cell culture flask(25㎠, 75㎠), 96 well plate- Cell culture flask (25 cm 2, 75 cm 2), 96 well plate

(2) 실험 순서(2) Procedure of experiments

a. DMEM 배지 (+10% FBS, 1% Antibiotics)에 B16F10 세포 배양a. B16F10 cells were cultured in DMEM medium (+ 10% FBS, 1% Antibiotics)

b. 배양한 세포를 Cell culture flask(25㎠)에 2×105 cells/flask로 분주하여 24시간 배양b. The cultured cells were divided into 2 × 10 5 cells / flask in a cell culture flask (25 cm 2), cultured for 24 hours

c. 배양액 제거 후 α-MSH(최종농도 50nM)이 포함된 배지 4.5㎖와 시료 0.5㎖를 첨가하여 48시간 배양 (※최종적으로 시료는 10배 희석)c. After removing the culture solution, 4.5 ml of medium containing α-MSH (final concentration 50 nM) and 0.5 ml of sample were added and cultured for 48 hours (*

d. 배양액 제거 후 새 배지로 교환하여 CCK-8 assay를 이용, 세포 독성 여부를 측정하고 독성이 없다고 판단되는 값(Cell Viability(% of control) ≥ 80%)에 대해서만 미백 효능 인정d. After removal of the culture medium, the cells were exchanged with a fresh medium, and cytotoxicity was measured using the CCK-8 assay. Only the cell viability (% of control) ≧ 80%

e. 세포를 Trypsin-EDTA를 이용하여 회수하고 배양액 제거 후 1M NaOHe. Cells were recovered using trypsin-EDTA, and after removing the culture solution, 1 M NaOH

(+10% DMSO) 용액을 이용하여 세포를 용해, 세포 내 멜라닌 획득(+ 10% DMSO) solution to dissolve cells and obtain intracellular melanin

f. 멜라닌이 용해된 lysate를 이용, 490nm에서 흡광도 측정하여 세포수 대비 멜라닌 합성량(%)을 계산f. Melanin-soluble lysate was used to measure the absorbance at 490 nm to calculate the amount of melanin synthesis (%) versus the number of cells

3) 미백 효능 평가 결과 (Melanogenesis inhibition assay)3) Melanogenesis inhibition assay

실시예 1의 조성물의 10배 희석액의 B16F10 세포에 대한 세포독성 실험 결과, 독성을 보이지 않았으며, 미백 효능평가(Melanogenesis inhibition assay) 결과, 멜라닌의 생성량이 α-MSH 단독처리군을 100% 기준으로 10배 희석액 처리군에서 약 85%로 나타나 생성량이 감소하는 것을 나타냈다.As a result of the cytotoxicity test on B16F10 cells of the 10-fold dilution of the composition of Example 1, no toxicity was observed, and as a result of the melanogenesis inhibition assay, the amount of melanin produced by the α-MSH group alone was 100% And about 85% in the group treated with 10 times dilution.

시험예Test Example 6: 주름 개선 효과 평가 6: Wrinkle improvement effect evaluation

40세 여성 10명을 선정하여 본 발명의 마스크팩을 주 1회 4주간 사용하게 하고 주름개선 효과를 평가하였다. 마스크패의 사용은 다음 순서로 하였다. 먼저, 상기 실시예 6에서 제조된 각질케어 필링용 패드를 사용하여 얼굴을 닦아내고, 실시예 7에서 제조된 피부진정용 소프트 패드를 사용하여 얼굴을 한번 더 닦아낸 후, 상기 실시예 5에서 제조된 에멀젼 함침 마스크 패드를 얼굴에 밀착시켜서 마스크팩을 실시하였다. 30분 후, 세안을 하였다. Ten women aged 40 years old were selected and the mask pack of the present invention was used once a week for 4 weeks, and the wrinkle improving effect was evaluated. The use of mask padding was performed in the following order. First, the face was wiped using the pad for keratin care filling produced in Example 6, and the face was wiped once more using the soft-skin softening pad prepared in Example 7. Thereafter, Impregnated mask pad was brought into close contact with the face to carry out the mask pack. After 30 minutes, the skin was cleansed.

4주 후, 주름의 완화정도를 육안판정 및 사진판정(개선없음, 약간의 개선, 중등도의 개선, 상당한 개선의 4 단계로 판정)으로 평가하여 하기 표 4에 나타내었다. After 4 weeks, the degree of relieving of the wrinkles was evaluated by visual and photographic judgment (no improvement, slight improvement, moderate improvement, and significant improvement in four stages) and is shown in Table 4 below.

총인원Total number of people 개선없음No improvement 약간의 개선Slight improvement 중증도의 개선Improvement of severity 상당한 개선A significant improvement 본 발명의 마스크팩 사용Use of the mask pack of the present invention 10명10 people 00 66 33 1One

상기 표 6에서 확인되는 바와 같이, 본 발명의 마스크팩은 매우 우수한 주름개선효과를 나타내었다. As shown in Table 6, the mask pack of the present invention exhibited a very excellent wrinkle-reducing effect.

Claims (6)

글리세린 1~8 중량%, 소듐하이알루로네이트 1~5 중량%, 복숭아추출물 1~7 중량%, 감초추출물 0.5~4 중량%, 소듐아세틸레이티드하이알루로네이트 1~8 중량%, 하이드롤라이즈드하이알루로닉애씨드 0.1~2 중량%, 하이드롤라이즈드콜라겐 0.1~3 중량%, 레몬추출물 0.1~3 중량%, 설탕 0.1~3 중량%, 단풍추출물 0.1~3 중량%, 빌베리열매 및 잎추출물 0.1~3 중량%, 사탕수수추출물 0.1~3 중량%, 오렌지추출물 0.1~3 중량%, 마치현추출물 0.1~3 중량%, 티트리잎추출물 0.1~3 중량%, 베르가못잎추출물 0.1~3 중량%, 대나무수 0.1~3 중량%, 동백꽃추출물 0.1~3 중량%, 판테놀디포타슘글리시리제이트 0.1~3 중량%, 알란토인 0.1~3 중량%, 베타인글리세릴아크릴레이트/아크릴릭애씨드 코폴리머 0.1~3 중량%, 피브이엠/엠에이 코폴리머 0.1~3 중량%, 프로필렌글라이콜 1~7 중량%, 하이드록시에칠아크릴레이트/소듐아크릴로일디메칠타우레이트 코폴리머 0.1~3 중량%, 잔탄검 0.01~0.3 중량%, 피이지-60 하이드로제네이티드캐스터오일 0.05~2 중량%, 1,2-핵산디올 0.1~1 중량%, 하이드록시아세토페논 0.1~1 중량%, 디소듐이디티에이 0.005~0.1 중량%, 향료 0.01~0.2 중량%, 및 정제수 잔량을 포함하는 에멀젼 조성물을 포함하는 마스크팩.1 to 8 wt% of glycerin, 1 to 5 wt% of sodium hyaluronate, 1 to 7 wt% of peach extract, 0.5 to 4 wt% of licorice extract, 1 to 8 wt% of sodium acetylated hyaluronate, 0.1 to 3 wt% of lemon extract, 0.1 to 3 wt% of sugar, 0.1 to 3 wt% of leaf extract, 0.1 to 3 wt% of berry fruit, 0.1 to 3 wt% of leaf extract, 0.1 to 3 wt% of sugar cane extract, 0.1 to 3 wt% of orange extract, 0.1 to 3 wt% of horseradish extract, 0.1 to 3 wt% of tea tree leaf extract, 0.1 to 3 wt of bergamot leaf extract 0.1 to 3 wt% of bamboo water, 0.1 to 3 wt% of camellia extract, 0.1 to 3 wt% of panthenol dipotassium glycyrrhizate, 0.1 to 3 wt% of allantoin, 0.1 to 3 wt% of betaine glyceryl acrylate / acrylic acid copolymer, 3 wt.%, PVEM / MEA copolymer 0.1-3 wt.%, Propylene glycol 1-7 wt.%, Hydroxyethyl methacrylate / 0.1 to 3% by weight of acryloyldimethyltaurate copolymer, 0.01 to 0.3% by weight of xanthan gum, 0.05 to 2% by weight of hydrogenated castor oil, 0.1 to 1% by weight of 1,2-nucleic acid diol, Wherein the emulsion composition comprises 0.1 to 1% by weight of a hydroxyacetophenone, 0.005 to 0.1% by weight of disodium iodide, 0.01 to 0.2% by weight of a perfume, and a purified water balance. 제1항에 있어서,
상기 에멀젼 조성물은 왕겨, 율피, 메밀껍질, 및 껍질 채로 건조한 작두콩을 1~3 : 1~3 : 1~3 : 1~3의 중량비로 혼합한 혼합물을 열수추출한 추출물 0.1~5 중량%를 더 포함하는 것을 특징으로 하는 마스크팩.
The method according to claim 1,
The emulsion composition further comprises 0.1 to 5% by weight of an extract obtained by hot-water extracting a mixture of rice hull, hull, buckwheat husk, and husked dried soybeans at a weight ratio of 1: 3: 1 to 3: 1 to 3: Wherein the mask pack is a mask pack.
제1항에 있어서,
상기 에멀젼 조성물은 유화보조제로서 하기 화학식 1로 표시되는 화합물 0.1~3 중량%를 더 포함하는 것을 특징으로 하는 마스크팩:
[화학식 1]
Figure 112017131383810-pat00005

상기 식에서,
n은 2~10의 자연수이고,
a 및 b는 몰분율으로서 a는 0.5 및 b는 0.5이며;
c 및 d는 몰분율으로서, c는 0.05~0.2이며, d는 0.8~0.95이며, c+d는 1이다.
The method according to claim 1,
Wherein the emulsion composition further comprises 0.1 to 3% by weight of a compound represented by the following formula (1) as an emulsifying aid:
[Chemical Formula 1]
Figure 112017131383810-pat00005

In this formula,
n is a natural number of 2 to 10,
a and b are molar fractions, a is 0.5 and b is 0.5;
c and d are mole fractions, c is 0.05 to 0.2, d is 0.8 to 0.95, and c + d is 1.
제1항에 있어서,
상기 마스크팩은 각질케어용 조성물 및 피부진정용 조성물을 상기 에멀젼 조성물과 각각 분리된 상태로 더 포함하는 것을 특징으로 하는 마스크팩.
The method according to claim 1,
Wherein the mask pack further comprises a composition for keratinocyte care and a composition for skin soothing, separately from the emulsion composition.
제4항에 있어서,
상기 각질케어용 조성물은 글리세린 1~8 중량%, 소듐하이알루로네이트 1~5 중량%, 메칠프로판디올변성알코올 0.5~4 중량%, 복숭아추출물 1~7 중량%, 감초추출물 0.5~4 중량%, 소듐아세틸레이티드하이알루로네이트 1~8 중량%, 하이드롤라이즈드하이알루로닉애씨드 0.1~2 중량%, 하이드롤라이즈드콜라겐 0.1~3 중량%, 레몬추출물 0.1~3 중량%, 설탕 0.1~3 중량%, 단풍추출물 0.1~3 중량%, 빌베리열매 및 잎추출물 0.1~3 중량%, 사탕수수추출물 0.1~3 중량%, 오렌지추출물 0.1~3 중량%, 마치현추출물 0.1~3 중량%, 티트리잎추출물 0.1~3 중량%, 락토바이오닉애씨드 0.1~3 중량%, 소듐락테이트, 0.1~3 중량%, 글라이콜릭애씨드 0.1~3 중량%, 디포타슘글리시리제이트 0.1~3 중량%, 알란토인 0.1~3 중량%, 피이지-60 하이드로제네이티드캐스터오일 0.05~2 중량%, 1,2-핵산디올 0.1~1 중량%, 하이드록시아세토페논 0.1~1 중량%, 디소듐이디티에이 0.005~0.1 중량%, 향료 0.01~0.2 중량%, 및 정제수 잔량을 포함하며;
상기 피부진정용 조성물은 메칠프로판디올글리세린 1~8 중량%, 소듐하이알루로네이트 1~5 중량%, 복숭아추출물 1~7 중량%, 감초추출물 0.5~4 중량%, 소듐아세틸레이티드하이알루로네이트 1~8 중량%, 하이드롤라이즈드하이알루로닉애씨드 0.1~2 중량%, 하이드롤라이즈드콜라겐 0.1~3 중량%, 레몬추출물 0.1~3 중량%, 설탕 0.1~3 중량%, 단풍추출물 0.1~3 중량%, 빌베리열매 및 잎추출물 0.1~3 중량%, 사탕수수추출물 0.1~3 중량%, 오렌지추출물 0.1~3 중량%, 마치현추출물 0.1~3 중량%, 티트리잎추출물 0.1~3 중량%, 베르가못잎추출물 0.1~3 중량%, 대나무수 0.1~3 중량%, 동백꽃추출물 0.1~3 중량%, 판테놀디포타슘글리시리제이트 0.1~3 중량%, 알란토인 0.1~3 중량%, 하이드록시에칠셀룰로오스 0.1~3 중량%, 글리세릴폴리아크릴레이트 0.1~3 중량%, 시트릭애씨드 0.1~3 중량%, 소듐시트레이트 0.1~3 중량%, 피이지-60 하이드로제네이티드캐스터오일 0.05~2 중량%, 1,2-핵산디올 0.1~1 중량%, 하이드록시아세토페논 0.1~1 중량%, 디소듐이디티에이 0.005~0.1 중량%, 향료 0.01~0.2 중량%, 및 정제수 잔량을 포함하는 것을 특징으로 하는 마스크팩.
5. The method of claim 4,
Wherein the composition for keratin care comprises 1 to 8 wt% of glycerin, 1 to 5 wt% of sodium hyaluronate, 0.5 to 4 wt% of methylpropanediol-modified alcohol, 1 to 7 wt% of peach extract, 0.5 to 4 wt% 1 to 8% by weight of sodium acetylated hyaluronate, 0.1 to 2% by weight of hydrolized hyaluronic acid, 0.1 to 3% by weight of hydrolized collagen, 0.1 to 3% by weight of lemon extract, 0.1 to 3% by weight of the leaves extract, 0.1 to 3% by weight of the leaves extract, 0.1 to 3% by weight of the extract of Bilberry fruit and leaf, 0.1 to 3% by weight of sugar cane extract, 0.1 to 3% 0.1 to 3 wt% of tea tree leaf extract, 0.1 to 3 wt% of lactobionic acid, 0.1 to 3 wt% of sodium lactate, 0.1 to 3 wt% of glycolic acid, 0.1 to 3 wt% of dipotassium glycyrrhizate, 0.1 to 3% by weight of allantoin, 0.05 to 2% by weight of a fat-60 hydrogenated castor oil, 0.1 to 1% by weight of a 1,2-nucleic acid diol, Non 0.1-1% by weight of the disodium dithiane A 0.005 ~ 0.1% by weight, comprising a perfume 0.01% to 0.2% by weight, and purified water balance;
Wherein the skin-soothing composition comprises 1 to 8% by weight of methylpropanediol glycerin, 1 to 5% by weight of sodium hyaluronate, 1 to 7% by weight of peach extract, 0.5 to 4% by weight of licorice extract, sodium acetylated hyaluronic acid 0.1 to 3% by weight of hydrolyzed collagen, 0.1 to 3% by weight of lemon extract, 0.1 to 3% by weight of sugar, 0.1 to 3% by weight of the extracts of Bilberry fruit and leaf extract, 0.1 to 3% by weight of sugar extract, 0.1 to 3% by weight of orange juice extract, 0.1 to 3% 0.1 to 3% by weight of bergamot leaf extract, 0.1 to 3% by weight of bamboo water, 0.1 to 3% by weight of camphor flower extract, 0.1 to 3% by weight of panthenol dipotassium glycyrrhizate, 0.1 to 3% by weight of allantoin, 0.1 to 3% by weight of fumed cellulose, 0.1 to 3% by weight of glyceryl polyacrylate, 0.1 to 3% by weight of citric acid, 0.1 to 3% 0.1 to 1% by weight of 1,2-nucleic acid diol, 0.1 to 1% by weight of hydroxyacetophenone, 0.005 to 0.1% by weight of disodium dipentaerythritol, 0.05 to 2% by weight of hydrogenated castor oil, 0.01 to 0.2% by weight of a perfume, and purified water balance.
제5항에 있어서,
상기 각질케어용 조성물은 필링용(Peelling) 패드에 함침되고; 피부진정용 조성물은 소프트 패드에 함침되며; 에멀젼 조성물은 마스크 패드에 함침되어 각각 분리된 상태로 밀봉되어 포함되는 것을 특징으로 하는 마스크팩.
6. The method of claim 5,
The composition for keratin care is impregnated with a peeling pad; The composition for skin soothing is impregnated with a soft pad; Wherein the emulsion composition is impregnated into a mask pad and sealed and contained separately.
KR1020170184874A 2017-12-29 2017-12-29 Mask pack comprising emulsion composition containing peach-extract KR101891951B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020170184874A KR101891951B1 (en) 2017-12-29 2017-12-29 Mask pack comprising emulsion composition containing peach-extract

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020170184874A KR101891951B1 (en) 2017-12-29 2017-12-29 Mask pack comprising emulsion composition containing peach-extract

Publications (1)

Publication Number Publication Date
KR101891951B1 true KR101891951B1 (en) 2018-08-27

Family

ID=63455312

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020170184874A KR101891951B1 (en) 2017-12-29 2017-12-29 Mask pack comprising emulsion composition containing peach-extract

Country Status (1)

Country Link
KR (1) KR101891951B1 (en)

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109602623A (en) * 2019-01-25 2019-04-12 云南群优生物科技有限公司 A kind of bamboo liquid skin care item and preparation method thereof
KR102003186B1 (en) * 2019-04-01 2019-07-23 강지윤 Cosmetic composition containing Andiroba oil and pracaxi oil and method for producing the same
CN110613676A (en) * 2019-11-01 2019-12-27 深圳美丽魔方健康科技有限公司 Chitosan marine peptide crystal facial mask
WO2021006413A1 (en) * 2019-07-11 2021-01-14 조성민 Dual modeling facial pack
CN112641695A (en) * 2021-01-13 2021-04-13 贵州大隆药业有限责任公司 Moisturizing and anti-aging mask and preparation method thereof
KR20210040522A (en) 2019-10-04 2021-04-14 박석 Cosmetic composition, cosmetic mask pack comprisint the same and preperation method of the cosmetic composition
CN112870098A (en) * 2021-04-08 2021-06-01 珠海朗祺生物科技有限公司 Composition containing acetylated sodium hyaluronate and having wrinkle removing effect and preparation method and application thereof
KR102282856B1 (en) * 2020-08-12 2021-07-28 주식회사 현진씨엔티 Scrub cosmetics and its manufacturing method
CN113491651A (en) * 2020-04-07 2021-10-12 中国科学院青岛生物能源与过程研究所 Soothing and repairing mask essence containing camellia extract and preparation method and application thereof
CN113876679A (en) * 2021-11-04 2022-01-04 天津郁美净集团有限公司 Multi-effect composition and essence with moisturizing and sensitive skin relieving functions and preparation method thereof
CN114306127A (en) * 2021-12-28 2022-04-12 华熙生物科技股份有限公司 Hyaluronic acid composition, negative electricity nano emulsion with good permeability and preparation method thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20170056148A (en) 2015-11-13 2017-05-23 성훈경 Mask pack composition for skin beauty and mask pack for skin beauty comprising the same

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20170056148A (en) 2015-11-13 2017-05-23 성훈경 Mask pack composition for skin beauty and mask pack for skin beauty comprising the same

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109602623A (en) * 2019-01-25 2019-04-12 云南群优生物科技有限公司 A kind of bamboo liquid skin care item and preparation method thereof
KR102003186B1 (en) * 2019-04-01 2019-07-23 강지윤 Cosmetic composition containing Andiroba oil and pracaxi oil and method for producing the same
WO2021006413A1 (en) * 2019-07-11 2021-01-14 조성민 Dual modeling facial pack
KR20210040522A (en) 2019-10-04 2021-04-14 박석 Cosmetic composition, cosmetic mask pack comprisint the same and preperation method of the cosmetic composition
CN110613676A (en) * 2019-11-01 2019-12-27 深圳美丽魔方健康科技有限公司 Chitosan marine peptide crystal facial mask
CN113491651A (en) * 2020-04-07 2021-10-12 中国科学院青岛生物能源与过程研究所 Soothing and repairing mask essence containing camellia extract and preparation method and application thereof
KR102282856B1 (en) * 2020-08-12 2021-07-28 주식회사 현진씨엔티 Scrub cosmetics and its manufacturing method
CN112641695A (en) * 2021-01-13 2021-04-13 贵州大隆药业有限责任公司 Moisturizing and anti-aging mask and preparation method thereof
CN112870098A (en) * 2021-04-08 2021-06-01 珠海朗祺生物科技有限公司 Composition containing acetylated sodium hyaluronate and having wrinkle removing effect and preparation method and application thereof
CN113876679A (en) * 2021-11-04 2022-01-04 天津郁美净集团有限公司 Multi-effect composition and essence with moisturizing and sensitive skin relieving functions and preparation method thereof
CN113876679B (en) * 2021-11-04 2023-09-01 天津郁美净集团有限公司 Multi-effect composition with moisturizing and sensitive skin relieving functions, essence and preparation method
CN114306127A (en) * 2021-12-28 2022-04-12 华熙生物科技股份有限公司 Hyaluronic acid composition, negative electricity nano emulsion with good permeability and preparation method thereof
CN114306127B (en) * 2021-12-28 2024-02-09 华熙生物科技股份有限公司 Hyaluronic acid composition, negative electricity nano emulsion with good permeability and preparation method thereof

Similar Documents

Publication Publication Date Title
KR101891951B1 (en) Mask pack comprising emulsion composition containing peach-extract
KR101785498B1 (en) Mask pack composition for skin beauty and mask pack for skin beauty comprising the same
KR102084505B1 (en) Whitening emulsion cosmetic composition containing Theobroma Cacao (Cocoa) Seed Butter and method for manufacturing the same
CN106137906A (en) A kind of plant essence Face-protecting mask essence
US20220218595A1 (en) Method of using soothing cream including maca root extract as an active ingredient
KR101119337B1 (en) Herb Cosmetic Composition for Skin Moisturizing and Soothing and Method for Preparing the Same
CN107714504A (en) A kind of same human-like collagen composition and its applied in cosmetics
KR101189989B1 (en) Cosmetic composition containing as available ingredient the extracts of Equisetum arvense L.
US8557795B2 (en) Composition containing Chamaecyparis obtusa polysaccharides to be externally applied to the skin
KR102016164B1 (en) Whitening emulsion cosmetic composition containing a vitamin tree fruit extract and method for manufacturing the same
KR101780486B1 (en) Cosmetic composition comprising echinacea purpurea extract
CN108601718A (en) For protecting skin to prevent composition of pollution effect and application thereof
CN104434642B (en) A kind of after-sun restorative skin whitening, moisturizing condensation and preparation method thereof
JP5856847B2 (en) Skin external preparation composition containing Matsune extract
FR3029417A1 (en) ACTIVE COMPLEX FOR A COSMETIC PRODUCT AGAINST SKIN AGING
KR20050110720A (en) Cosmetic composition for moisturizing effect on the skin
KR101662272B1 (en) Natural cosmetic composition for skin moisturizing comprising Mixed extract of barley and germ and rice bran of black rice and preparation method thereof
CN104188808B (en) A kind of nti-freckle is dispelled yellow gel and preparation method thereof
CN106176360A (en) A kind of nectar frost containing oral shui solution extract, Herba Saussureae Involueratae extract and Echinacea Angustifolia extracts and preparation method thereof
EP3506985B1 (en) Cosmetic use of an extract of arbutus unedo
KR20060093164A (en) Anti-wrinkle cosmetic composition
KR101558186B1 (en) Cosmetic composition containing Phyllanthus urinaria extrancts
KR102024167B1 (en) Skin temperature sensitive gel composition comprising bee venom and mask pack using the same
KR20220078809A (en) Two layered trouble care cosmetic composition with complex functions
JP5047511B2 (en) Granulocyte / macrophage colony stimulating factor (GM-CSF) production inhibitor I

Legal Events

Date Code Title Description
GRNT Written decision to grant